Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2026)
Perspective Therapeutics recorded quarterly Change in Interest Receivables of $392000.0 in Q1 2026, up 340.49% quarter-over-quarter from -$163000.0 in Q4 2025, and up 429.73% year-over-year from $74000.0 in Q1 2025.
Perspective Therapeutics' Change in Interest Receivables history runs 3 years deep, the most recent figure standing at $392000.0 for Q1 2026.
- In Q1 2026, Change in Interest Receivables rose 429.73% year-over-year to $392000.0; the TTM figure through Mar 2026 stood at $460000.0 (down 51.78% YoY), while the FY2025 annual figure was $142000.0, down 83.86% from the prior year.
- Change in Interest Receivables came in at $392000.0 for Q1 2026 at Perspective Therapeutics, up from -$163000.0 in the prior quarter.
- In the past five years, Change in Interest Receivables ranged from a high of $880000.0 in Q4 2024 to a low of -$163000.0 in Q4 2025.
- A 3-year average of $235666.7 and a median of $143000.0 in 2025 frame the typical range for Change in Interest Receivables.
- Across the five-year window, Change in Interest Receivables slumped 118.52% in 2025 and jumped 429.73% in 2026, its largest moves.
- Perspective Therapeutics' Change in Interest Receivables stood at $880000.0 in 2024, then plunged by 118.52% to -$163000.0 in 2025, then surged by 340.49% to $392000.0 in 2026.
- According to Business Quant data, Change in Interest Receivables over the past three periods registered $392000.0, -$163000.0, and $19000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | -163,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 212,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 880,000.00 |